All Q2 FY26 results →
GA

Gujarat Alkalies & Chemicals Ltd

Q2 FY26

Gujarat Alkalies & Chemicals Q2 FY26 investor presentation: Revenue & Margins

Q2 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹585
Market cap₹4.3K Cr
P/E64.8
Updated16 Oct 2026
Read3 min read

Based on Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Net External Sales Value for H1 2025-26 is Rs. EBITDA (H1 2025-26): Rs.

From Gujarat Alkalies & Chemicals Ltd's Q2 FY26 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

  • Net External Sales Value for H1 2025-26 is Rs. 2,136.64 Crores (Page 21).
  • For full years:
  • 2023-24: Rs. 3,702.77 Crores
  • 2024-25: Rs. 3,959.50 Crores
  • Year-on-Year (YoY) change from 2023-24 to 2024-25 in Net External Sales Value: increase of Rs. 256.73 Crores (~6.93%).
  • No explicit quarterly or H1 YoY figures provided for direct comparison.
  • No explicit revenue or volume outlook for future quarters or years stated in the presentation.

2 more points from Gujarat Alkalies & Chemicals Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Gujarat Alkalies & Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Caustic Soda Flaking Unit: 200 TPD capacity; under implementation (Page 12)
  • HCl Synthesis Unit: 400 TPD (as 31% HCl); under implementation (Page 12)
  • Chlorotoluenes Downstream Products: 40 TPD; under implementation (Page 12)
  • Upgradation of Cell Elements: 275 TPD capacity; under implementation (Page 12)
  • New Chlorotoluene capacity at Dahej: 30,000 MTPA; commissioned March 2025 (Page 18)
  • Sodium Chlorate plant at Dahej: 20,000 MTPA; commissioned 2014 (Page 18)
  • Green Energy Initiatives (additional to existing 207.87 MW captive):
  • 95 MW Solar Power (Short term)
  • 55 MW Solar Power (Short term)

2 more points from Gujarat Alkalies & Chemicals Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Fundraising & Capital Structure

See what Gujarat Alkalies & Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly mention order book, order inflow, or pending orders in the provided content. The key financial and operational data presented include: - Financial details such as sales, EBITDA, profit, equity, reserves, and loans (Page 21). - Financial ratios including earnings per share, dividend per share, and book value per share (Page 22). - Capacity utilization of major product lines (Page 19). - Existing products and their contributions (Pages 14-15).

2 more points from Gujarat Alkalies & Chemicals Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Gujarat Alkalies & Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Sep 2024Q2 FY25
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26

Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹1.0K Cr, net loss ₹20 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Platinum Industries Ltd (Q2 FY26)

    Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri

  • Galaxy Surfactants Ltd (Q2 FY26)

    Capital Work-in-Progress (CWIP) was around INR 260 crores as of FY '25. Key concall takeaways from Galaxy Surfactants Ltd's Q2 FY26 earnings call — and how it…

  • Aether Industries Ltd (Q2 FY26)

    EBITDA margins are sustainable at 29%-30%, supported by increasing contract manufacturing and CRAMS business. Key concall takeaways from Aether Industri.'s Q2…

  • Neogen Chemicals Ltd (Q2 FY26)

    Neogen Chemicals rebuilding plant with potential incremental capex post insurance evaluation, mostly double-digit crores, no large capex planned next 1-2…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Gujarat Alkalies & Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Gujarat Alkalies & Chemicals Ltd Q2 FY26 results?

Net External Sales Value for H1 2025-26 is Rs. EBITDA (H1 2025-26): Rs.

What is Gujarat Alkalies & Chemicals Ltd share price analysis?

Gujarat Alkalies & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 64.8 with a market cap of ₹4,297 Cr. Investors should review the full earnings analysis for detailed insights.

Is Gujarat Alkalies & Chemicals Ltd planning capital expenditure?

Caustic Soda Flaking Unit: 200 TPD capacity; under implementation (Page 12) - HCl Synthesis Unit: 400 TPD (as 31% HCl); under implementation (Page 12) - Chlorotoluenes Downstream Products: 40 TPD;

Keep Gujarat Alkalies & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.